Lgt Financial Advisors LLC Amgen Inc Transaction History

Lgt Financial Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $2,301 - $2,596	-9 Reduced 0.45%	2,000 $576 Million
Q3 2023 Nov 01, 2023	SELL	$218.65 - $271.46 $51,601 - $64,064	-236 Reduced 10.51%	2,009 $540 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $53,286 - $64,947	236 Added 11.75%	2,245 $543 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $460,121 - $584,639	2,009 New	2,009 $528 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Lgt Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Lgt Financial Advisors LLC with notifications on news.